Transaction in Own Shares

Summary by AI ^BETAClose X

Bodycote plc has announced its share buyback program activity for the week of March 30 to April 3, 2026, during which it purchased 159,589 ordinary shares for cancellation. These purchases were made through Barclays Bank plc as part of the initial £40 million tranche of an £80 million share repurchase program. The volume-weighted average price paid per share was 616.81 pence, with the highest price at 643.00 pence and the lowest at 593.00 pence. Following these transactions, Bodycote will have 172,207,896 ordinary shares in issue, with no shares held in treasury, representing the total voting rights.

Disclaimer*

www.bodycote.com

7 April 2026

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that in the week 30 March to 3 April 2026, it purchased for cancellation the following number of its ordinary shares of 17 3 / 11 pence each (Ordinary Shares) through Barclays Bank plc, as part of the first £40 million tranche of the £80 million share repurchase programme announced on 11 March 2026 (the ‘Programme’). All Ordinary Shares were purchase from Barclays Bank plc as an ‘on exchange’ transaction subject to the rules of the London Stock Exchange.

Dates of purchase:	30 March – 2 April 2026
Total number of ordinary shares purchased:	159,589
Highest price paid per share (pence per share):	643.00p
Lowest price paid per share (pence per share):	593.00p
Volume weighted average price paid per share (pence per share)	616.81p

Since the commencement of this Programme, the Company has purchased 554,694 Ordinary Shares in aggregate for cancellation from Barclays Bank plc in accordance with the Programme. Following the above purchases and cancellation of these Ordinary Shares, the Company will have 172,207,896 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a breakdown of the individual trades made by Barclays as principal on behalf of the Company in connection with the above purchases is detailed in the attachment. Purchases made under Programme will be announced on a weekly basis.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Edward Knight

Tel: +44 203 727 1340